Moderna shares surge 10% on earnings beat and raised revenue outlook

Investing.com · Louis Juricic · 2026-11-06 12:20 UTC

Moderna shares surge 10% on earnings beat and raised revenue outlook

Investing.com -- Moderna Inc. reported third-quarter earnings that significantly exceeded analyst expectations, prompting shares to jump 10% as the biotechnology company raised its full-year revenue growth forecast.

Moderna posted adjusted earnings of $0.38 per share, beating analyst expectations for a loss of $1.09 per share by $1.47. Revenue totaled $1.31 billion, topping the consensus estimate of $892.41 million and increasing 29% from $1.01 billion in the same quarter a year earlier.

The company raised its 2026 revenue growth outlook to 15%-25%, compared with its previous forecast of growth of up to 10%. It also significantly increased its expected year-end cash balance to $8.1 billion-$8.3 billion, up from its prior estimate of $4.7 billion-$5.2 billion.

Read the full story at Investing.com · All coverage of this story